Medical Devices
-
Boston Scientific, Blackstone agree to $455M deal to co-fund heart pump development
As part of the agreement, Blackstone may receive regulatory and commercial milestone payments, plus royalties on net sales.
By Nick Paul Taylor • Nov. 5, 2026 -
MiniMed names David Segal chief medical officer
Segal is succeeding Robert Vigersky, who is transitioning to a chief medical officer emeritus role ahead of his planned retirement at the end of next year.
By Nick Paul Taylor • Nov. 5, 2026 -
Explore the Trendline➔
Sarah Silbiger via Getty Images
TrendlineTop 5 stories from MedTech Dive
From the effects of layoffs at the Food and Drug Administration and President Donald Trump’s tariff policies to the top medtech trends of 2026, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
Zimmer raises sales forecast despite slower knee business
CEO Ivan Tornos did not attribute the company’s performance in knees to a broader market slowdown, as competitor Stryker did last week.
By Elise Reuter • Nov. 4, 2026 -
Philips settles with DOJ over recalled CPAP machines
Philips will pay 288 million euros to settle an investigation related to its recall of millions of sleep and respiratory devices.
By Elise Reuter • Nov. 4, 2026 -
3 takeaways from TCT 2026
Edwards’ TAVR results in moderate aortic stenosis drew applause from meeting attendees, while Medtronic’s renal denervation and Abbott’s left atrial appendage closure devices also produced positive study findings.
By Susan Kelly • Nov. 4, 2026 -
Q&A
AdvaMed Chair Mick Farrell shares his top priorities, challenges for the medtech industry
In a year where companies are grappling with cyberattacks, inflation and potential tariffs, Farrell, who is also CEO of Resmed, shared a bird’s eye view of the issues.
By Elise Reuter • Nov. 2, 2026 -
Abbott starts pivotal trial for mitral valve replacement device
The study is testing a device that Abbott executives believe can expand the mitral valve market.
By Nick Paul Taylor • Nov. 2, 2026 -
FDA posts alert about Medline beds linked to 2 deaths
The company notified customers this month that it will discontinue Medline brand beds and associated products and exit the market.
By Nick Paul Taylor • Oct. 30, 2026 -
Cooper Companies CEO steps down after activist investor pressure
Weeks after an investor called for leadership changes, Cooper has parted ways with its CEO and proposed a new-look board of directors.
By Nick Paul Taylor • Oct. 29, 2026 -
Abbott grows cardiac portfolio with Amplatzer approval for valve leaks
The first-of-its-kind transcatheter device treats paravalvular leak after valve replacement surgery, to spare the patient from another open-heart surgery.
By Susan Kelly • Oct. 29, 2026 -
RadNet expands into teleradiology with $350M Onrad deal
The acquisition, which will give RadNet a new professional services unit, is expected to help hospitals solve challenges with radiology coverage.
By Nick Paul Taylor • Oct. 28, 2026 -
Stryker completes ZuriMED takeover
The deal expands Stryker’s portfolio of fast-growing sports medicine and shoulder care devices.
By Nick Paul Taylor • Oct. 27, 2026 -
The MedTech Conference 2026
Medical device leaders share AI hot takes at The MedTech Conference
Medtech CEOs and consultants advised focusing on a core market and preparing for complex processes in a highly regulated industry.
By Elise Reuter • Oct. 27, 2026 -
The MedTech Conference 2026
Overheard in Boston: Medtech CEOs talk rising costs, turbulent markets, cyberattacks
At AdvaMed’s The MedTech Conference, CEOs from top medical device companies shared how they navigate difficult times, inflation and new technologies.
By Elise Reuter • Oct. 26, 2026 -
Sponsored by JR Automation
Reshoring prompts crucial decisions for medical device manufacturers
For medical device manufacturers, reshoring has been discussed for years. Now, many are putting it into action and hitting familiar capacity challenges along the way.
Oct. 26, 2026 -
Medtech leaders discuss AI, cybersecurity and M&A at AdvaMed’s The MedTech Conference
More than 4,000 people across the medtech sector met in Boston for one of the industry’s biggest events of the year. Catch up on all the conference news in MedTech Dive’s roundup.
By Elise Reuter • Oct. 23, 2026 -
Edwards wins FDA approval for tricuspid valve repair device
Edwards’ approval should “strengthen the company’s position in the large and underpenetrated transcatheter tricuspid market,” analysts said.
By Nick Paul Taylor • Oct. 23, 2026 -
Retrieved from Olympus on October 22, 2026
FDA flags more Olympus safety problems in import block and warning letter
The FDA import alert broadens the scope of a 2025 import action covering dozens of endoscopes and comes two weeks after a new warning letter identified numerous quality system violations.
By Susan Kelly • Oct. 22, 2026 -
Intuitive’s US da Vinci procedure growth slows again
Facing continued softness, Intuitive outlined opportunities to increase use of its robots in benign general surgeries.
By Nick Paul Taylor • Oct. 21, 2026 -
The MedTech Conference 2026
Expect more tuck-in M&A, portfolio pruning in medtech, execs say
As medical device makers face “finite” capital, portfolio reshaping will likely remain a focus in the sector.
By Susan Kelly • Oct. 21, 2026 -
The MedTech Conference 2026
Cybersecurity in focus for top medtech lobby
ResMed CEO Mick Farrell, chair of AdvaMed’s board, said the group plans to come up with standards around privacy, cybersecurity and interoperability.
By Elise Reuter • Oct. 20, 2026 -
The MedTech Conference 2026
Medtech execs share secrets to building resilient supply chains
At AdvaMed’s The MedTech Conference, company executives said they’re bracing for disruption by investing in inventory, scenario planning and their relationships with chip suppliers.
By Susan Kelly • Oct. 20, 2026 -
Medtronic wins CE mark for Vitalis portfolio of cardiac pacemakers
The CE mark clears Medtronic to sell conduction system pacing therapy devices in Europe.
By Nick Paul Taylor • Oct. 20, 2026 -
FDA clears Sequel’s insulin delivery system in Type 2 diabetes
With Twiist already available in Type 1 diabetes, Sequel has made the automated insulin delivery system available for the Type 2 population.
By Nick Paul Taylor • Oct. 19, 2026 -
Edwards recall of Sapien mitral delivery systems tied to 1 death
Edwards is asking customers to return some of the delivery systems used with its Sapien M3 devices after receiving three reports of balloons bursting when inflated during the procedure.
By Susan Kelly • Oct. 16, 2026